You just read:

CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno-Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

News provided by

Jazz Pharmaceuticals plc

Aug 02, 2016, 19:15 ET